Autoimmune hepatitis: Clinical manifestations and diagnostic criteria

Canadian Journal of Gastroenterology

Volumn 15, Issue 2, 2001, Pages 107-113

  McFarlane, I G ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Chronic liver disease; Diagnostic criteria; Scoring systems

Indexed keywords

AUTOANTIBODY;

AUTOIMMUNE HEPATITIS; BIOCHEMISTRY; CHOLESTASIS; CHRONIC HEPATITIS; CLINICAL FEATURE; DATA ANALYSIS; DIAGNOSTIC ACCURACY; HISTOLOGY; HUMAN; LIVER DISEASE; PATHOLOGY; PRIORITY JOURNAL; REVIEW; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; VIRUS HEPATITIS;

EID: 0035098363     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2001/279637     Document Type: Review

References (103)

1. International working party: Terminology of chronic hepatitis
2. Idiopathic jaundice (often recurrent) associated with subacute necrosis of the liver
3. Hyperproteinaemia associated with severe liver damage
4. Non-suppurative hepatitis: A study of acute and chronic forms with special reference to biochemical and histological changes
5. Leber, blutproteine und Nahrungsweiss
6. Adrenal cortical metabolism in chronic liver disease
7. The course of infectious hepatitis with special reference to prognosis and chronic stage
8. Chronic liver disease in young people. Clinical features and course of thirty-three patients
9. Natural history of active chronic hepatitis
10. Clinical, biochemical and histological remission of severe chronic active liver disease: A controlled study of treatments and early prognosis
11. The LE cell phenomenon in active chronic viral hepatitis
12. Heterogenetic antibodies in acute hepatitis
13. Extreme hyperglobulinemia in subacute hepatic necrosis
14. Lupoid hepatitis
15. Lupoid hepatitis and the hepatic lesions of systemic lupus erythematosus
16. An "autoimmune" reaction against human tissue antigens in certain acute and chronic diseases: I. Serological investigations
17. An "autoimmune" reaction against human tissue antigens in certain acute and chronic diseases: II. Clinical correlations
18. Antinuclear factor and other antibodies in blood and liver diseases
19. Antibody to smooth muscle in patients with liver disease
20. Smooth muscle autoantibody in 'autoimmune' hepatitis
21. The treatment of active chronic infectious hepatitis with ACTH (corticotrophin) and cortisone
22. The treatment of active chronic hepatitis and lupoid hepatitis with 6-mercaptopurine and azathioprine
23. Effect of prednisolone on the survival of patients with cirrhosis of the liver
24. Controlled prospective trial of corticosteroid therapy in active chronic hepatitis
25. Clinical, biochemical and histological remission of severe chronic active liver disease: A controlled trial of treatments and early prognosis
26. Controlled trial of prednisone and azathioprine in active chronic hepatitis
27. Autoimmune hepatitis
28. Inadequate antibody response to HBAg or suppressor T-cell defect in development of active chronic hepatitis
29. Association of autoimmune active hepatitis with HL-A1,8
30. HLA determinant in chronic active liver disease: A possible relation of HLA-Dw3 to prognosis
31. Association of autoimmune hepatitis with HLA Bw54 and DR4 in Japanese patients
32. Susceptibility to autoimmune chronic active hepatitis: Human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors
33. Immunogenetics of autoimmune hepatitis in Japanese
34. Immunogenetic studies of autoimmune hepatitis and primary sclerosing cholangitis
35. Clinical aspects of autoimmune hepatitis in North America
36. Clinical characteristics of autoimmune hepatitis in Japan
37. Enhanced antibody responses in active chronic hepatitis: Relation to HLA-B8 and HLA-B12 and porto-systemic shunting
38. Effect of corticosteroids on suppressor-cell activity in "autoimmune" and viral chronic active hepatitis
39. IgG production in "autoimmune" chronic active hepatitis. Effect of prednisolone on T and B lymphocyte function
40. HLA A1-B8-DR3 and suppressor cell function in first-degree relatives of patients with autoimmune chronic active hepatitis
41. Genetically determined low C4: A predisposing factor to autoimmune chronic active hepatitis
42. Cell-mediated immunity and discrete suppressor T-cell defects to liver-derived antigens in families of patients with autoimmune chronic active hepatitis
43. Early-onset autoimmune hepatitis is associated with a C4 gene deletion
44. Polymorphisms in the human complement C4 genes and genetic susceptibility to autoimmune hepatitis
45. Autoimmune chronic active hepatitis
46. The natural course and heterogeneity of autoimmune-type chronic active hepatitis
47. Clinical spectrum and heterogeneity of autoimmune hepatitis: An overview
48. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome
49. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis
50. Autoimmunity and hepatotropic viruses
51. Is autoimmune hepatitis a HCV-related disease?
52. Antibodies to hepatitis C virus in autoimmune liver disease: Evidence for geographical heterogeneity
53. Non-organ specific autoantibodies associated with chronic C virus hepatitis
54. Autoimmune responses as assessed by hypergammaglobulinaemia and the presence of autoantibodies in patients with chronic hepatitis C
55. Clinical and serological differentiation of autoimmune hepatitis and hepatitis C virus-related chronic hepatitis
56. Survival and histological resolution of fibrosis in patients with autoimmune chronic active hepatitis
57. Prognosis of histological cirrhosis in type 1 autoimmune hepatitis
58. Does corticosteroid pretreatment enhance the effect of alfa interferon treatment in chronic hepatitis B?
59. Hepatitis C viremia in chronic liver disease: Relationship to interferon-alpha or corticosteroid treatment
60. Autoimmune hepatitis and/or hepatitis C: How to decide
61. Thyroid abnormalities in chronic viral hepatitis and their relationship to interferon alpha therapy
62. Alpha-interferon treatment of chronic hepatitis C: Need for accurate diagnosis in selecting patients
63. Chronic active hepatitis associated with anti-liver/kidney microsome antibody type 1: A second type of "autoimmune" hepatitis
64. Autoimmune features in patients with idiopathic chronic active hepatitis who are seronegative for conventional auto-antibodies
65. The nature and prognosis of severe cryptogenic chronic active hepatitis
66. Meeting report: International autoimmune hepatitis group
67. Towards diagnostic criteria for autoimmune hepatitis
68. Diagnostic criteria, clinical manifestations and natural history of autoimmune hepatitis
69. The nature of unexplained chronic aminotransferase elevations of a mild to moderate degree in asymptomatic patients
70. The nature and prognostic implications of autoimmune hepatitis with an acute presentation
71. International autoimmune hepatitis group report: Review of criteria for diagnosis of autoimmune hepatitis
72. The relationship between autoimmune markers and different clinical syndromes in autoimmune hepatitis
73. Type 1 autoimmune hepatitis is primarily a disease of later life
74. Present status of autoimmune hepatitis in Japan - Correlating the characteristics with international criteria in an area with a high rate of HCV infection
75. Autoimmune hepatitis in older patients
76. Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis
77. Characterisation of anti-histone antibodies in patients with type 1 autoimmune hepatitis
78. Antinuclear antibodies and patterns of nuclear immunofluorescence in type 1 autoimmune hepatitis
79. Antineutrophil cytoplasmic antibody in inflammatory bowel and hepatobiliary diseases: High prevalence in ulcerative colitis, primary sclerosing cholangitis, and autoimmune hepatitis
80. Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver disease
81. Segregation of pANCA antigenic recognition by DNase treatment of neutrophils: Ulcerative colitis, type 1 autoimmune hepatitis and primary sclerosing cholangitis
82. High-titer antineutrophil cytoplasmic antibodies in type-1 autoimmune hepatitis
83. Anti-neutrophil cytoplasmic antibodies in type 1 and 2 autoimmune hepatitis
84. Autoimmune hepatitis in childhood: A 20-year experience
85. Antibodies to soluble liver antigen, P450IID6, and mitochondrial complexes in chronic hepatitis
86. GBV-C/HGV is not the major cause of autoimmune hepatitis
87. Distinction between autoimmune and viral liver diseases
88. Autoimmune hepatitis type 1 without evidence of hepatitis G virus infection
89. Interferon and prednisone therapy in chronic hepatitis C with non-organ-specific antibodies
90. Autoantibody prevalence in chronic hepatitis B virus infection: Effect of interferon alpha
91. Serum autoantibodies in chronic hepatitis C: Comparison with autoimmune hepatitis and impact on disease profile
92. Autoantibody prevalence in children with liver disease due to chronic hepatitis C virus (HCV) infection
93. Epitope mapping of cytochrome P4502D6 autoantigen in patients with chronic hepatitis C during a-interferon therapy
94. Autoimmune cholangitis. A variant of primary biliary cirrhosis: Clinicopathological and serologic correlations in 200 cases
95. Comparison of the clinical features and clinical course of antimitochondrial antibody - Positive and negative primary biliary cirrhosis
96. Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantation
97. Overlap syndromes of autoimmune hepatitis, primary biliary cirrhosis and primary sclerosing cholangitis
98. Autoimmune cholangitis and primary biliary cirrhosis - An autoimmune enigma
99. Primary sclerosing cholangitis in 32 children: Clinical, laboratory, and radiographic features, with survival analysis
100. Post infantile giant cell hepatitis in patients with primary sclerosing cholangitis and autoimmune hepatitis
101. Autoimmune hepatitis in children
102. Primary sclerosing cholangitis in children
103. Features of autoimmune hepatitis in primary sclerosing cholangitis: An evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis